Drug-Device Combination Products Market Trends, Growth Analysis, Investigation by Regions, Types, Applications and Analysis of Key Players

The QY Research released a latest market research report on the Global Drug-Device Combination Products market, which is segmented by region (country), company and by Application. Players, stakeholders, and other participants in the global Drug-Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application of Global Drug-Device Combination Products market.

For More Information About This Report, Please Enter:

https://us.qyresearch.com/reports/348697/drug-device-combination-products

Summary

The research report studies the Drug-Device Combination Products market using different methodologies and analyses to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

The global Drug-Device Combination Products market size is projected to reach US$ 117202 million by 2027, from US$ 76220 million in 2020, at a CAGR of 6.24% during 2021-2027.

The report mentions the prominent market player consisting of:

GSK

Novo Nordisk

Eli Lilly

AstraZeneca

Sanofi

Boston Scientific

Abbott

Boehringer Ingelheim

Medtronic

Mylan

3M

Hisamitsu

Smith & Nephew

Molnlycke

Teleflex

BD

Lepu Medical

MicroPort

Terumo

Braun

Antares Pharma

Drug-Device Combination Products Market Segment by Type

Drug-Coated Device

Prefilled Drug Delivery Systems

Nebulizer & Inhaler

Transdermal Delivery System

Other

Drug-Device Combination Products Market Segment by Application

Hospital & Clinic

Retail Pharmacies

Other

The report on the Drug-Device Combination Products market covers the following region (country) analysis:

North America

United States

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Europe

Germany

France

U.K.

Italy

Russia

South America

Brazil

Middle East & Africa

Middle East

Africa

 

The Goal of the Report

To study and analyze the global Drug-Device Combination Productsconsumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Drug-Device Combination Productsmarket by identifying its various subsegments.
Focuses on the key global Drug-Device Combination Productsmanufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drug-Device Combination Productswith respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Drug-Device Combination Productssubmarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Target Audience

> Drug-Device Combination Products companies

> Research organizations

> Government Organizations

> Research/Consultancy firms

Table of Contents

 

1 MARKET OVERVIEW OF DRUG-DEVICE COMBINATION PRODUCTS 1
1.1.1 Drug-Device Combination Products Product Scope 1
1.1.2 Drug-Device Combination Products Market Status and Outlook 2
1.2.1 Drug-Coated Device 4
1.2.2 Prefilled Drug Delivery Systems 5
1.2.3 Nebulizer & Inhaler 7
1.2.4 Transdermal Delivery System 9
1.3.1 Global Drug-Device Combination Products Market Size Overview by Type (2016-2027) 11
1.3.2 Global Drug-Device Combination Products Historic Market Size Review by Type (2016-2021) 12
1.3.3 Global Drug-Device Combination Products Forecasted Market Size by Type (2022-2027) 13
1.4.1 North America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 14
1.4.2 Europe Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 15
1.4.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 16
1.4.4 South America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 17
1.4.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 18

2 DRUG-DEVICE COMBINATION PRODUCTS MARKET COMPETITION BY COMPANY 20

2 and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020) 22
2.6.1 Drug-Device Combination Products Market Concentration Rate 25
2.6.2 Mergers & Acquisitions, Expansion Plans 26

3 DRUG-DEVICE COMBINATION PRODUCTS STATUS AND OUTLOOK BY REGION 28

2016 VS 2021 VS 2027 28

4 DRUG-DEVICE COMBINATION PRODUCTS MARKET OVERVIEW BY APPLICATION 32
4.1.1 Hospital & Clinic 32
4.1.2 Retail Pharmacies 33
4.2.1 Global Drug-Device Combination Products Market Size Overview by Application (2016-2027) 34
4.2.2 Global Drug-Device Combination Products Historic Market Size by Application (2016-2021) 36
4.2.3 Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027) 36
4.3.1 North America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 37
4.3.2 Europe Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 38
4.3.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 39
4.3.4 South America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 40
4.3.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 41

5 NORTH AMERICA 43

6 EUROPE 46

7 ASIA-PACIFIC 51

8 SOUTH AMERICA 57

9 MIDDLE EAST & AFRICA 59

10 COMPANY PROFILES AND KEY FIGURES IN DRUG-DEVICE COMBINATION PRODUCTS BUSINESS 61
10.1.1 GSK Corporation Information 61
10.1.2 GSK Introduction and Business Overview 61
10.1.3 GSK Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 62
10.1.4 GSK Drug-Device Combination Products Offered 62
10.1.5 GSK Recent Development 64
10.2.1 Novo Nordisk Corporation Information 64
10.2.2 Novo Nordisk Introduction and Business Overview 65
10.2.3 Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 65
10.2.4 Novo Nordisk Drug-Device Combination Products Offered 66
10.2.5 Novo Nordisk Recent Development 66
10.3.1 Eli Lilly Corporation Information 66
10.3.2 Eli Lilly Introduction and Business Overview 67
10.3.3 Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 67
10.3.4 Eli Lilly Drug-Device Combination Products Offered 67
10.3.5 Eli Lilly Recent Development 68
10.4.1 AstraZeneca Corporation Information 69
10.4.2 AstraZeneca Introduction and Business Overview 69
10.4.3 AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 69
10.4.4 AstraZeneca Drug-Device Combination Products Offered 70
10.4.5 AstraZeneca Recent Development 71
10.5.1 Sanofi Corporation Information 71
10.5.2 Sanofi Introduction and Business Overview 72
10.5.3 Sanofi Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 72
10.5.4 Sanofi Drug-Device Combination Products Offered 72
10.5.5 Sanofi Recent Development 73
10.6.1 Boston Scientific Corporation Information 73
10.6.2 Boston Scientific Introduction and Business Overview 74
10.6.3 Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 74
10.6.4 Boston Scientific Drug-Device Combination Products Offered 75
10.6.5 Boston Scientific Recent Development 76
10.7.1 Abbott Corporation Information 76
10.7.2 Abbott Introduction and Business Overview 77
10.7.3 Abbott Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 77
10.7.4 Abbott Drug-Device Combination Products Offered 77
10.8.1 Boehringer Ingelheim Corporation Information 78
10.8.2 Boehringer Ingelheim Introduction and Business Overview 79
10.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 79
10.8.4 Boehringer Ingelheim Drug-Device Combination Products Offered 79
10.8.5 Boehringer Ingelheim Recent Development 80
10.9.1 Medtronic Corporation Information 81
10.9.2 Medtronic Introduction and Business Overview 81
10.9.3 Medtronic Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 82
10.9.4 Medtronic Drug-Device Combination Products Offered 82
10.9.5 Medtronic Recent Development 83
10.10.1 Mylan Corporation Information 83
10.10.2 Mylan Introduction and Business Overview 84
10.10.3 Mylan Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 84
10.10.4 Mylan Drug-Device Combination Products Offered 85
10.10.5 Mylan Recent Development 86
10.11.1 3M Corporation Information 86
10.11.2 3M Introduction and Business Overview 86
10.11.3 3M Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 87
10.11.4 3M Drug-Device Combination Products Offered 87
10.12.1 Hisamitsu Corporation Information 88
10.12.2 Hisamitsu Introduction and Business Overview 89
10.12.3 Hisamitsu Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 89
10.12.4 Hisamitsu Drug-Device Combination Products Offered 90
10.13.1 Smith & Nephew Corporation Information 90
10.13.2 Smith & Nephew Introduction and Business Overview 91
10.13.3 Smith & Nephew Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 91
10.13.4 Smith & Nephew Drug-Device Combination Products Offered 91
10.13.5 Smith & Nephew Recent Development 93
10.14.1 Molnlycke Corporation Information 93
10.14.2 Molnlycke Introduction and Business Overview 93
10.14.3 Molnlycke Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 94
10.14.4 Molnlycke Drug-Device Combination Products Offered 94
10.15.1 Teleflex Corporation Information 95
10.15.2 Teleflex Introduction and Business Overview 95
10.15.3 Teleflex Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 96
10.15.4 Teleflex Drug-Device Combination Products Offered 96
10.15.5 Teleflex Recent Development 97
10.16.1 BD Corporation Information 97
10.16.2 BD Introduction and Business Overview 97
10.16.3 BD Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 98
10.16.4 BD Drug-Device Combination Products Offered 98
10.17.1 Lepu Medical Corporation Information 99
10.17.2 Lepu Medical Introduction and Business Overview 99
10.17.3 Lepu Medical Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 100
10.17.4 Lepu Medical Drug-Device Combination Products Offered 100
10.18.1 MicroPort Corporation Information 102
10.18.2 MicroPort Introduction and Business Overview 102
10.18.3 MicroPort Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 103
10.18.4 MicroPort Drug-Device Combination Products Offered 103
10.19.1 Terumo Corporation Information 104
10.19.2 Terumo Introduction and Business Overview 105
10.19.3 Terumo Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 105
10.19.4 Terumo Drug-Device Combination Products Offered 105
10.20.1 B. Braun Corporation Information 106
10.20.2 B. Braun Introduction and Business Overview 107
10.20.3 B. Braun Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 107
10.20.4 B. Braun Drug-Device Combination Products Offered 107
10.21.1 Antares Pharma Corporation Information 109
10.21.2 Antares Pharma Introduction and Business Overview 110
10.21.3 Antares Pharma Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 110
10.21.4 Antares Pharma Drug-Device Combination Products Offered 110

11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 112
11.1.1 Key Raw Materials 112
11.1.2 Key Raw Materials Market Concentration Rate 112
11.1.3 Raw Materials Key Suppliers 112
11.2.1 Raw Materials 113
11.2.2 Labor Cost 113
11.2.3 Manufacturing Expenses 113
11.4.1 Drug-Device Combination Products Industry Trends 114
11.4.2 Drug-Device Combination Products Market Drivers 115
11.4.3 Drug-Device Combination Products Market Challenges 116
11.4.4 Drug-Device Combination Products Market Restraints 116

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 117

13 RESEARCH FINDING/CONCLUSION 122

14 METHODOLOGY AND DATA SOURCE 124
14.1.1 Research Programs/Design 124
14.1.2 Market Size Estimation 125
14.1.3 Market Breakdown and Data Triangulation 126
14.2.1 Secondary Sources 127
14.2.2 Primary Sources 128

Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click 

https://us.qyresearch.com/reports/348697/drug-device-combination-products

Any doubts and questions will be welcome.

Customization of the Report:

This report can be customized to meet the client's requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.

About Us:

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

Contact Us

QY Research

E-mail: global@qyresearch.com

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

The QY Research released a latest market research report on the Global Drug-Device Combination Products market, which is segmented by region (country), company and by Application. Players, stakeholders, and other participants in the global Drug-Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application of Global Drug-Device Combination Products market.

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

This release was published on openPR.